Document Detail

Glucocorticoid ameliorates early cardiac dysfunction after coronary microembolization and suppresses TGF-β1/Smad3 and CTGF expression.
MedLine Citation:
PMID:  22727959     Owner:  NLM     Status:  Publisher    
OBJECTIVES: This study was designed to evidence the protective effect of glucocorticoid therapy on cardiac dysfunction after coronary microembolization (CME), and to clarify its mechanism with the expression of transforming growth factor-beta 1 (TGF-β1)/Smad3 and connective tissue growth factor (CTGF). METHODS: Eighteen mini-pigs were studied, including Sham-operation group (n=4), CME group (n=8) and Glucocorticoid therapy group (n=6, received methylprednisolone 25mg/kg intravenously 30min before CME). Magnetic resonance imaging (3.0-T) was performed at baseline, 6th hour and one week after operation to evaluate cardiac function. Serum TGF-β1, CTGF and troponin T were also detected. Myocardial expressions of TGF-β1, CTGF and Smad3 were detected by western blot and immunohistochemistry. Total collagen expression was demonstrated by Masson Trichrome stain. RESULTS: Compared with Sham-operation group, left ventricular end-systolic volume (LVESV) and left ventricular end-diastolic volume (LVEDV) in CME group were increased at 6th hour after CME, while left ventricular ejection fraction (LVEF) was decreased significantly. Compared with CME group, methylprednisolone greatly improved LVEF after CME (6th hour: 56.0±3.2% vs. 51.8±3.8%, P=0.030; one week: 57.8±3.2% vs. 54.6±2.6%, P=0.053). We found that methylprednisolone not only significantly decreased serum TGF-β1, CTGF and troponin T, but also reduced myocardial expressions of TGF-β1, CTGF and Smad3 after CME. In addition, collagen volume fraction in glucocorticoid therapy group was markedly lower than that in CME group. CONCLUSIONS: Glucocorticoid therapy could improve early cardiac function after CME, and its mechanism could be associated with TGF-β1/Smad3 and CTGF suppression.
Zhangwei Chen; Juying Qian; Jianying Ma; Shufu Chang; Hong Yun; Hang Jin; Aijun Sun; Yunzeng Zou; Junbo Ge
Related Documents :
7840049 - Pathophysiologic aspects of end-stage heart failure.
17188569 - Clinical trials update from the american heart association 2006: oat, salt 1 and 2, mag...
25411159 - Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main re...
10907969 - Advances in the treatment of congestive heart failure: new approaches for an old disease.
8668609 - Evolving concepts in the treatment of heart failure: should new inotropic agents carry ...
15891699 - Implications of heart failure drug trials: comet, charm, ephesus.
10080429 - Association of left ventricular systolic performance and cavity size with angiotensin-c...
7349939 - In-hospital prognosis of patients with first nontransmural and transmural infarctions.
1291199 - Evaluation of the effect of ptcr/ptca by 99mtc-mibi myocardial imaging in acute and old...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-22
Journal Detail:
Title:  International journal of cardiology     Volume:  -     ISSN:  1874-1754     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-6-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, PR China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Thrombospondin-1 Mimetic Peptide ABT-898 Affects Neovascularization and Survival of Human Endometrio...
Next Document:  Brown fat like gene expression in the epicardial fat depot correlates with circulating HDL-cholester...